RecruitingNCT06368648
CoMind Early Feasibility Study
Studying Encephalitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- CoMind Technologies Limited
- Principal Investigator
- Ramani Balu, MD, PhDInova Fairfax Hospital
- Enrollment
- 581 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2024 – 2026
Study locations (14)
- UC Davis Medical Center, Sacramento, California, United States
- Christiana Care, Wilmington, Delaware, United States
- Medstar Health, Washington D.C., District of Columbia, United States
- Jackson Memorial Hospital, Miami, Florida, United States
- The University of Kansas Medical Center, Kansas City, Kansas, United States
- Washington University Medical Center, St Louis, Missouri, United States
- Albany Medical College, Albany, New York, United States
- Stony Brook University Hospital, Stony Brook, New York, United States
- WakeMed, Raleigh, North Carolina, United States
- Ohio State University, Columbus, Ohio, United States
- University of Pennsylvania Hospital, Philadelphia, Pennsylvania, United States
- Vanderbilt University Medical Center, Nashville, Tennessee, United States
- Inova Fairfax Medical Campus, Falls Church, Virginia, United States
- University of Washington, Harborview, Seattle, Washington, United States
Collaborators
Lindus Health
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06368648 on ClinicalTrials.govOther trials for Encephalitis
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07332234Optic Nerve Ultrasound for Assessing Cerebral Inflammation and Intracranial Hypertension in Cerebral PathologiesSpitalul Clinic de Boli Infecțioase și tropicale "Dr. Victor Babeș"
- ACTIVE NOT RECRUITINGNCT06820060Clinical Performance of QIAstat-Dx® Meningitis/Encephalitis (ME) Panel PlusQIAGEN Gaithersburg, Inc
- ACTIVE NOT RECRUITINGPHASE2NCT06899802A Phase 2 Trial in Healthy Adult Participants of the Recombinant MVA-BN-WEV VaccineBavarian Nordic
- RECRUITINGPHASE1, PHASE2NCT06680128A Study to Assess the Safety, Reactogenicity, and Immunogenicity of SK Japanese Encephalitis Messenger Ribonucleic Acid (mRNA) Vaccines (GBP560) in Healthy AdultsSK Bioscience Co., Ltd.
- ACTIVE NOT RECRUITINGPHASE4NCT06678373Monitoring JE Antibody Levels in Healthy Populations and Immunization Strategy in Low-Prevalence AreasLiaoning Chengda Biotechnology CO., LTD
- RECRUITINGPHASE2NCT06510426Early Interferon-beta Treatment for West-Nile Virus InfectionTel-Aviv Sourasky Medical Center
- RECRUITINGNCT07191223Evaluation of Knowledge on Tick-borne Encephalitis Virus (TBEV) Infection Among General Practitioners in FranceUniversity Hospital, Strasbourg, France
- RECRUITINGNCT07251049Acute Infectious Encephalitis and Myelitis in Guadeloupe by New Generation SequencingCentre Hospitalier Universitaire de la Guadeloupe